Recalls / Firms / Genentech, Inc.
Genentech, Inc.
11 FDA drug recalls on record — 2 Class I.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2024-05-20 | Class II | Cathflo Activase | Terminated |
| 2022-10-18 | Class III | Susvimo | Terminated |
| 2021-06-09 | Class II | Xolair | Terminated |
| 2021-04-20 | Class III | Evrysdi (risdiplam) for oral solution, 60 mg/80mL (0.75mg/mL), 80 mL total volume after co | Terminated |
| 2018-02-05 | Class III | Klonopin (clonazepam) 0.5 mg Tablets,100-count bottle, Rx only. Made in Canada, Distribute | Terminated |
| 2017-09-05 | Class I | Activase (alteplase), 100 mg (58 million IU), Lyophilized vial, packaged with 1 single-dos | Terminated |
| 2017-03-13 | Class II | Cotellic | Terminated |
| 2012-09-27 | Class III | CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles p | Terminated |
| 2012-09-20 | Class II | Nutropin AQ NuSpin 10 (somatropin (rDNA origin) injection} 10 mg/ 2mL Genentech, South San | Terminated |
| 2012-09-20 | Class II | Nutropin AQ NuSpin 20 (somatropin (rDNA origin) injection} 20 mg/ 2mL Genentech, South San | Terminated |
| 2012-07-30 | Class I | Trastuzumab Kit containing 1 vial Trastuzumab (nominal content: 440 mg); 1 20 mL multiple | Terminated |